Absence of Fingerprints Congenital Milia Syndrome

Absence of fingerprints–congenital milia syndrome is a very rare inherited skin condition in which a person is born without the usual ridge patterns on the fingertips, palms, and soles (this is called adermatoglyphia) and also has tiny white cysts on the skin called milia, often on the face at birth or in early infancy. Fingerprints normally form from skin ridges that grow in the womb around weeks 10–16 of pregnancy. In this syndrome, the program that builds those ridges is disrupted, so the ridges do not develop or are very weak. Because the ridges also guide the openings of sweat glands, people with this condition may sweat less on the hands and feet and can feel heat intolerance. The milia are small, firm, white bumps made of trapped keratin (skin protein) under the surface; they are harmless but can be cosmetically bothersome.

The condition is most often autosomal dominant (it can pass from an affected parent to a child). A well-known genetic cause is a change in a skin-specific form of the SMARCAD1 gene. Other rare disorders that involve similar ridge changes (like Naegeli-Franceschetti-Jadassohn syndrome and Dermatopathia pigmentosa reticularis) can look related, but the classic picture here is isolated lack of fingerprints with congenital milia and mild sweating problems, without major problems in hair, teeth, or overall health. Most people live normal lives, but they may face practical problems with biometric identification and with skin care on hands and feet.

Basan syndrome, a form of congenital adermatoglyphia (no fingerprints) that presents in newborns with congenital milia (tiny white facial bumps) and neonatal acral blisters that heal quickly. It is typically inherited in an autosomal-dominant pattern and is caused by variants in the skin-specific isoform of the SMARCAD1 gene. There is no curative medicine today; care focuses on gentle skin care, protecting fragile newborn skin, and optionally clearing milia if they persist. Genetic counseling is useful for families. OrphaMonarch InitiativePMC

This condition means a baby is born without the normal skin ridges on the fingertips, palms, toes, and soles. Because these ridges are what make fingerprints and toeprints, the child has no fingerprints. Along with this, many babies have small white bumps on the face called milia and may get small blisters on the hands and feet soon after birth. The blisters heal on their own. Some people also have less sweating on the hands/feet, easy friction injuries, and, in a few families, mild nail changes or tight finger joints. Brain, heart, eyes, and general growth are usually normal. Most children live normal lives; the main day-to-day impact is practical (for example, trouble with fingerprint-based IDs) and simple skin care to avoid friction and treat milia if bothersome. The genetic change is in SMARCAD1, a gene important for skin ridge development before birth. MedlinePlusPMCPubMed

This syndrome means you are born without fingerprints and with little white bumps (milia) on the face or elsewhere. The skin on the palms and soles looks smoother than usual, and sweating can be reduced there. The milia are small, white, harmless cysts. The condition runs in families. Daily life is usually normal, but phones, bank systems, or border control machines that need fingerprints may not work, and hot weather can feel harder to tolerate.

---

Other names

• Adermatoglyphia (absence of dermatoglyphs/fingerprints)

• Adermatoglyphia with congenital facial milia

• SMARCAD1-related adermatoglyphia

• Congenital absence of fingerprints

• Immigration delay disease (informal name used because lack of fingerprints can slow identity checks)

• Isolated adermatoglyphia (when no other major ectodermal features are present)

---

Types

1. Isolated SMARCAD1-related adermatoglyphia: Classic form with absent/very faint fingerprints, mild palm/sole sweating reduction, and facial milia in infancy.

2. Adermatoglyphia with prominent congenital milia: Same core findings, but milia are numerous and may recur beyond infancy.

3. Partial adermatoglyphia: Ridges are reduced or fragmented rather than fully absent; some fingers may scan poorly while others scan sometimes.

4. Generalized ridge loss of hands and feet: Near-complete lack of ridges on both palms/soles and all fingertips/toes.

5. Segmental/patchy presentation: Ridge loss is more obvious in certain zones (for example, thenar area of palms) with milia mainly on the face.

6. Syndromic adermatoglyphia (look-alikes): Conditions such as Naegeli-Franceschetti-Jadassohn (NFJ) or Dermatopathia pigmentosa reticularis (DPR) show adermatoglyphia plus extra features (reticulate skin pigmentation, dental issues, nail changes). They are distinct disorders but part of the differential.

7. Severity by sweating: From almost normal sweating to hypohidrosis (reduced sweat) on palms/soles with heat intolerance.

8. Course by milia behavior: (a) Transient milia that fade in infancy; (b) Recurrent milia needing periodic removal.

---

Causes

Note: “Cause” here means either a direct genetic reason for the classic syndrome or a closely related developmental path that can produce absent/weak fingerprints with milia or a very similar picture.

1. SMARCAD1 skin-specific isoform mutation: The most typical cause of isolated adermatoglyphia. A change near a skin-only exon alters how the gene is read in skin, so epidermal ridges fail to form normally.

2. Disrupted fetal ridge formation (weeks 10–16): Even without a known gene, anything that disturbs growth of volar pads (the fetal cushions that shape ridges) can leave the fingertips smooth.

3. KRT14 (keratin 14) variants—reticulate pigmentary disorders: In NFJ and DPR, keratin 14 changes weaken the basal layer of the epidermis; poor ridge development can include adermatoglyphia.

4. KRT5 (keratin 5) pathway disturbance: Similar to KRT14 in maintaining the basal epidermis; rare variants can affect ridge robustness and sweat duct openings.

5. TP63-related ectodermal dysplasias: Disorders like EEC (ectrodactyly-ectodermal dysplasia-clefting) can blunt or distort ridges and reduce sweat function.

6. WNT10A-associated ectodermal dysplasia: Abnormal signaling in ectoderm can lead to ridge underdevelopment and milia tendencies.

7. EDA/EDAR pathway defects (hypohidrotic ectodermal dysplasia): Reduced or altered sweat gland development may pair with weak ridge patterns.

8. Adams–Oliver spectrum (scalp/limb skin morphogenesis): Rarely, altered limb skin development can include ridge anomalies.

9. In utero epidermolysis/bullous changes: Fetal blistering on friction areas (palms/soles) can scar or flatten early-forming ridges.

10. Amniotic band or localized intrauterine pressure: External pressure can flatten volar pads at a critical time, leaving smooth areas.

11. Placental vascular variations affecting limb skin: Subtle blood flow changes can modify ridge molding during the narrow developmental window.

12. Maternal hyperthermia or fever during ridge formation window: Heat stress can transiently alter fetal skin dynamics (rare, suggested mechanism).

13. Retinoid pathway disturbance in early gestation: Excess retinoic signaling can affect keratinization; theoretically may blunt ridges and promote milia formation.

14. Congenital ichthyosis spectra (palmar involvement): When palmar keratinization is abnormal from birth, ridge patterns may be poorly visible or interrupted.

15. Localized dermal scarring present at birth: Any congenital scar over fingertip pads will erase the ridge template in that zone.

16. Novel or private family variants in ridge-building genes: Undiscovered gene changes likely explain families with classic features but normal known-gene testing.

17. Altered sweat duct development: Sweat ducts open at ridge crests; if ducts are sparse or misplaced, ridges do not stabilize well.

18. Desmosomal/cornification pathway variation: Subtle defects in skin cell attachment or cornified envelope can weaken ridge relief.

19. Keratin plugging tendency (milia predisposition): A background tendency to form keratin cysts (milia) may travel with ridge underdevelopment in some families.

20. Epigenetic regulation of skin morphogenesis: Changes in how skin genes are switched on/off (without DNA sequence change) may contribute to the ridge-and-milia pattern in rare cases.

---

Symptoms

1. No fingerprints: Fingertips look smooth or have very faint, broken lines; scanners often cannot read them.

2. Smooth palms/soles: The normal “pebbly” feel is reduced; skin may look glassy in some areas.

3. Congenital milia: Small, white, firm bumps on the face (cheeks, nose, eyelids) at birth or early infancy; may recur.

4. Reduced sweating on hands/feet (hypohidrosis): Palms and soles may stay dry even in heat.

5. Heat intolerance: Hot weather, saunas, or vigorous exercise may feel harder because sweating helps cooling.

6. Hand/foot dryness: Skin can crack or peel, especially in dry climates.

7. Mild palmoplantar hyperkeratosis: Slight thickening or callus-like areas may appear with age or friction.

8. Trouble with fingerprint-based devices: Phone unlock, time clocks, or border control kiosks may fail, causing delays.

9. Frustration or anxiety during ID checks: Practical and social stress around proving identity.

10. Sensitivity to friction: Long writing, tool use, or sports may irritate smooth skin more easily.

11. Cosmetic concern about milia: Visible facial bumps can affect self-confidence.

12. Occasional nail or hair subtle changes: Usually mild or absent in isolated cases, more in syndromic forms.

13. Family clustering: Several relatives may share “no fingerprints” and childhood milia.

14. Normal overall growth and health: In isolated adermatoglyphia, general health is typically good.

15. Psychosocial planning needs: People learn alternate ID methods (passcodes, documents) and heat-management habits.

---

Diagnostic tests

A) Physical Examination

1. Careful look at fingertip, palm, and sole skin
   The clinician studies the hands and feet under good light and magnification. In this syndrome the skin shows absent or very faint ridges, giving a smooth look. The rest of the skin is checked to rule out other conditions that cause pigment changes or scarring.

2. Milia survey and skin mapping
   Small white bumps are counted and mapped, usually on the face. This helps separate transient newborn milia from recurrent milia that persist or return later. The doctor also looks for signs of other ectodermal findings (hair, teeth, nails) to decide whether it is an isolated condition or part of another syndrome.

3. Sweat function at the bedside (starch–iodine/Minor test)
   Iodine is painted on a small area of the palm, then starch powder is applied. When sweat appears, it turns the powder dark. In this syndrome the test may show reduced or patchy sweating on palms/soles.

4. Callus and skin thickness check
   Palms and soles are felt for thickened spots (hyperkeratosis) or cracks. These can develop because smooth skin handles friction differently. This exam also looks for tenderness or small fissures that need care.

5. Family examination or photos
   Because the condition often runs in families, relatives’ hands may be inspected (or photos reviewed) to look for the same ridge pattern loss and history of milia. A family pattern supports a genetic cause.

B) Manual Tests

6. Inked fingerprint/footprint capture
   Traditional ink printing on paper is attempted. In this condition the paper shows blank or very pale fingertip patterns. This provides a simple, low-tech record and is helpful for documentation.

7. Digital fingerprint scanner trial
   A clinic may try different scanners (capacitive, optical). Repeated failure across devices supports adermatoglyphia. The result is noted for practical advice (e.g., relying on passcodes instead of fingerprints).

8. Grip and fine-motor check (peg or pinch tests)
   Short tasks check how smooth skin affects grip. Most people do fine, but the test can guide tips such as using grip sleeves or chalk for specific activities or jobs.

9. Heat challenge walk with symptoms log
   A brief, supervised walk in a warm room (or standardized step test) is paired with notes on overheating or dizziness. This is not a strain test; it simply helps connect sweating reduction to real-life heat tolerance.

C) Laboratory & Pathological Tests

10. Targeted genetic test for SMARCAD1
    A blood or saliva sample is checked for known SMARCAD1 changes in the skin-specific exon or nearby splice sites. A positive result strongly supports isolated adermatoglyphia.

11. Expanded ectodermal dysplasia gene panel
    If SMARCAD1 is negative, a panel can look at KRT14, KRT5, TP63, WNT10A, EDA/EDAR, and related genes. This helps rule in/out syndromic look-alikes that also reduce ridges.

12. Skin biopsy of a milia lesion
    A tiny bump can be removed under local anesthesia. Under the microscope it shows a small keratin cyst just under the surface. This confirms that the white bumps are milia and not another condition.

13. Skin punch biopsy from a palm/sole area (selected cases)
    A 2–3 mm sample can show flattened epidermal ridges and eccrine duct openings that are fewer or misplaced. This is not always needed but can answer difficult diagnostic questions.

14. Immunohistochemistry for keratin profile
    Stains for keratin 14/5 and other markers assess the basal epidermis. Abnormal patterns may point toward a keratin-related syndrome rather than isolated SMARCAD1 disease.

15. Pilocarpine iontophoresis sweat test (quantitative)
    A medicine (pilocarpine) is driven into a small skin area to stimulate sweat, which is collected and measured. Low sweat output on palms/soles supports the clinical picture (this is separate from testing for cystic fibrosis; here it is used to quantify sweating).

D) Electrodiagnostic/Physiologic Tests

16. QSART (Quantitative Sudomotor Axon Reflex Test)
    This test measures sweat production triggered by nerves in a small skin region. In this syndrome, results can show reduced sudomotor response on palms/soles, helping document function.

17. Sympathetic skin response / galvanic skin response
    Electrodes detect tiny skin electrical changes linked to sweat gland activity. Flattened or absent responses on the hands/feet are consistent with reduced sweat function.

18. Thermoregulatory sweat test (TST)
    The whole body is lightly dusted with a color-changing powder and gently warmed in a controlled setting. Areas that sweat change color. Patchy or absent color change on palms/soles helps visualize the problem.

E) Imaging-type Skin Tests

19. Dermoscopy of fingertips and milia
    A handheld scope magnifies the skin. On fingertips it shows missing ridge relief and fewer eccrine pores; on milia it shows a white/yellow round structure beneath thin skin.

20. Reflectance confocal microscopy (RCM) or high-frequency ultrasound
    These noninvasive tools image the top layers of skin. They can demonstrate reduced ridge architecture and the structure of milia cysts without a surgical biopsy in some cases.

Non-pharmacological treatments

There is no medicine that “creates” fingerprints. Care is supportive: protect newborn skin, manage milia if desired, prevent friction blisters, teach families how to handle ID issues, and offer genetic counseling. Evidence is mostly expert consensus and small case series from Basan/adermatoglyphia reports. OrphaPubMed

A) Physiotherapy / mind–body / gene-education supports

1. Newborn skin-handling training – gentle lifting, no adhesive tapes on palms/soles, loose mittens/socks; reduces blistering in the first months.

2. Friction-minimizing hand therapy – padded grips, silicone sleeves for tools/pens; allows school/work without hot spots.

3. Footwear modification – wide toe box, smooth inner lining, moisture-wicking socks to cut shear.

4. Hydro-soaks (lukewarm water) 5–10 minutes then pat dry and apply bland ointment; softens crusts and supports barrier repair.

5. Targeted stretching of finger joints (if tight) guided by a therapist; maintains range of motion. PMC

6. Cooling strategies in warm weather – handheld fans, cool packs, shade breaks; important with reduced sweating to avoid overheating. MedlinePlus

7. Protective dressings for hot spots – thin hydrocolloid or silicone gel sheeting on areas that rub; prevents blisters similar to protocols in other fragile-skin conditions.

8. Hand-care routine education – short, lukewarm washes; fragrance-free cleansers; immediate emollient; avoid harsh sanitizers (or follow sanitizers with emollient).

9. Milia care counseling – explain that infant milia usually disappear; options if persistent (see below). Wiley Online Library

10. Sun/heat planning – schedule outdoor sports at cooler times; hydrate frequently.

11. Occupational therapy for grip devices – customized grips for writing, racquets, garden tools.

12. School/Work accommodation letter – explains why fingerprint biometrics may fail; suggests PIN/ID card alternatives (practical quality-of-life step). PMC

13. Travel/immigration documentation plan – carry physician note and alternative IDs (passport, retina/face ID) to avoid problems at borders. PMC

14. Family genetic counseling – inheritance, options for future pregnancies, and how to talk with relatives. PMC

15. Peer/psychological support – brief counseling if appearance concerns or ID frustrations cause stress.

B) Additional skin-care measures

16. Bland emollients (petrolatum, ceramide creams) twice daily to reduce friction and micro-cracks.

17. Non-adhesive dressings for blisters (if they occur); lance large tense blisters sterilely only under medical guidance and cover with silicone dressings; they typically heal quickly in Basan syndrome. Orpha

18. Avoid strong exfoliants in infants; the skin is delicate—keep routines simple.

19. Switch to fragrance-free laundry products to limit irritation.

20. Nail care – keep nails short and smooth to avoid scratching fragile areas.

21. Foot orthotics if repeated sole blisters; spreads pressure.

22. Sports choices – start with low-shear hobbies (swimming with soft shoes, cycling with padded gloves).

23. Heat safety plan – know heat-illness signs since sweating on palms/soles can be reduced (dizziness, cramps, headache). MedlinePlus

24. Teacher/coach education – quick note explaining the condition to prevent misunderstandings.

25. Home first-aid kit – silicone dressings, petrolatum, gentle cleanser, and a doctor-approved antiseptic.

---

Drug treatments

1. Topical retinoids for persistent milia – tretinoin 0.025–0.05% cream thin layer nightly 2–3 months; helps shed keratin so milia open. Side effects: dryness, peeling, light sensitivity; avoid in pregnancy; do not use in infants unless prescribed. Wiley Online Library

2. Adapalene 0.1% gel nightly as a gentler alternative for milia; same precautions. Wiley Online Library

3. Tazarotene 0.045–0.1% for resistant adult milia; more irritating.

4. Emollient ointments (white petrolatum) liberally after washing to reduce friction—safe at all ages.

5. Urea 10% cream once–twice daily for rough palms/soles; softens thick spots; stings on cuts.

6. Lactic acid 5–12% lotion nightly for dry, scaly areas; avoid if stinging.

7. Salicylic acid 2–6% limited, spot use on thick areas in teens/adults; avoid in infants; risk of irritation/salicylate toxicity if overused.

8. Topical antibiotics (mupirocin) for any secondarily infected blisters/erosions; short courses only.

9. Oral antibiotics (e.g., cephalexin) if spreading skin infection (cellulitis) is suspected; dose and duration per clinician.

10. Antihistamines (cetirizine at night) for itch or sleep disruption during healing; may cause drowsiness.

11. Low-potency topical steroids (hydrocortisone 1%) short course for inflamed dermatitis around lesions; avoid long use on face/infants.

12. Antiseptic cleansers (chlorhexidine) diluted/brief use on oozing erosions if a doctor recommends; can irritate.

13. Analgesics – acetaminophen or ibuprofen for painful blisters, as age-appropriate; avoid ibuprofen if contraindicated.

14. Barrier pastes (zinc oxide) to protect hot-spot areas in toddlers.

15. Prescription keratolytic combinations (e.g., urea + lactic acid compounded) for stubborn palm/sole roughness in older patients.

Evidence note: These medicines are used to manage milia, dryness, friction, or secondary infection—they treat symptoms, not the genetic cause. Basan syndrome itself usually needs minimal medication because blisters heal rapidly and milia often resolve spontaneously. Orpha

---

Dietary “molecular” supplements

1. Omega-3 fatty acids (EPA/DHA 1–2 g/day in adults) – may support skin barrier and calm inflammation; can thin blood at high doses.

2. Vitamin D (per level; often 800–2000 IU/day in adults if low) – skin/immune support; test first to avoid excess.

3. Zinc (10–20 mg elemental/day short term) – helps wound healing; excess causes copper deficiency.

4. Vitamin C (500–1000 mg/day adults) – collagen synthesis and antioxidant support.

5. Biotin (5–10 mg/day adults) – marketed for hair/nails; hard evidence limited; may interfere with lab tests.

6. Niacinamide (oral 500 mg/day adults, or topical 2–5%) – barrier and pigment-evening effects; mild GI upset possible.

7. Collagen peptides (2.5–10 g/day) – small trials suggest modest skin benefits.

8. Hyaluronic acid oral (120–240 mg/day) – hydration support; evidence modest.

9. Probiotics (strain-specific, daily) – may reduce atopic-type irritation in some people; strain matters.

10. Whey protein/hydrolyzed protein (as food) – general wound-healing support if intake is low.

These do not change fingerprints; they aim to support general skin healing.

---

Regenerative / stem-cell” drug ideas

(important reality check: there are no approved regenerative or stem-cell drugs for adermatoglyphia/Basan syndrome. Below are research-concept directions only; if pursued, they should be clinical-trial–only.)

1. Ex-vivo keratinocyte gene correction (research concept) – Correct the SMARCAD1 variant in a patient’s skin cells and graft back corrected sheets (borrows from methods used for epidermolysis bullosa). Status: not available for Basan; discussed here to show the path science might take. PMC

2. In-vivo topical gene delivery (analogous concept) – For EB, the FDA approved Vyjuvek (beremagene geperpavec) in 2023 to deliver a working COL7A1 gene and heal EB wounds. No such therapy exists for SMARCAD1 conditions; it simply shows the platform is feasible for some skin genes. U.S. Food and Drug AdministrationASGCT

3. Autologous gene-corrected epidermal sheets – In 2025 the FDA approved prademagene zamikeracel (Zevaskyn / pz-cel) for recessive dystrophic EB; again, not for Basan, but proves cell-sheet gene therapy can work in skin. Reuters

4. Base-editing or splice-editing of the skin-specific SMARCAD1 isoform – theoretical approach to fix the recurrent splice-site variant reported in families; strictly preclinical at this time. PMC

5. Induced-pluripotent stem cell (iPSC)-derived skin grafts (research) – future platform to create corrected, ridge-forming skin; no human data for Basan.

6. Topical small-molecule pathway modulators – hypothetical modifiers of ridge development; no current candidates.

---

Procedures / “surgeries

Most babies do not need procedures. These options are for cosmetic or recurrent-problem cases, performed by dermatology:

1. Manual milia extraction – tiny sterile needle nick and gentle expression; instant clearance of a visible milia; may need repeat if new cysts form. Wiley Online Library

2. Electrodesiccation of clustered milia – fine-tip cautery for resistant groups in older children/adults.

3. CO₂ or erbium:YAG laser for widespread persistent facial milia – smooths the surface in trained hands.

4. Punch excision for giant/atypical milia – when a cyst is large or diagnostic doubt exists.

5. Release of tight finger contracture (rare) – if significant contracture limits function; individualized surgical/hand-therapy plan. PMC

---

Preventions

1. Gentle newborn care – avoid strong friction/adhesives on hands/feet.

2. Heat safety – plan shade breaks; hydrate; watch for heat stress because sweating on palms/soles can be reduced. MedlinePlus

3. Soft, well-fitting shoes and gloves for sports/work.

4. Regular emollients to lower friction.

5. Protective dressings on known hot spots during long activities.

6. Fragrance-free skin and laundry products to minimize irritation.

7. Teacher/coach/travel letters explaining non-functional fingerprints and alternative ID methods. PMC

8. Keep nails short to reduce scratch injuries.

9. Prompt care of any blister to prevent infection.

10. Family genetic counseling before future pregnancies to understand inheritance and options. PMC

---

When to see a doctor

• Newborn period: any baby with unusual blisters, many facial milia, or absent fingerprints should see a pediatric dermatologist or genetics clinic for correct diagnosis.

• Any age: if blisters are large/painful, skin looks infected (spreading redness, pus, fever), milia are persistent and bothersome, there is hand/foot pain limiting function, or you face serious ID problems (immigration, banking).

• Family planning: seek genetic counseling if you or a relative has the condition.

---

What to eat / what to avoid

What to eat (supports skin healing):

1. Plenty of water (age-appropriate) in hot weather.

2. Protein with each meal (eggs, fish, legumes, tofu) to support skin repair.

3. Colorful fruits/vegetables (vitamin C, polyphenols).

4. Healthy fats (olive oil, nuts, seeds; oily fish 2×/week).

5. Zinc sources (beans, lentils, seafood) and vitamin D as advised if low.

What to limit/avoid:

1. Very spicy/salty foods before heat exposure (thirst, discomfort).
2. Dehydrating drinks (excess soda/energy drinks) in hot weather.
3. High-fragrance/“detox” herbal supplements that irritate skin or interact with medicines.
4. Megadose vitamin A (risk of toxicity; topical retinoids are enough if prescribed).
5. Any supplement in infants unless your pediatrician recommends it.

---

FAQs

1) Will fingerprints ever appear later?
No. The ridges fail to form before birth due to a SMARCAD1 variant, so fingerprints remain absent lifelong. Function in daily life is otherwise normal. PMC

2) Are milia dangerous?
No. Infant milia are harmless and usually clear on their own within months; treatment is optional and cosmetic. Wiley Online Library

3) Do the newborn blisters scar?
They usually heal rapidly without scarring in Basan syndrome. Keep them clean, covered, and see your clinician if infection signs appear. Orpha

4) Is this the same as epidermolysis bullosa (EB)?
No. EB is a different group of blistering disorders. We mention EB only to illustrate how skin gene therapy has advanced; those therapies do not treat Basan syndrome. U.S. Food and Drug AdministrationReuters

5) How common is this condition?
Extremely rare; only small numbers of families described worldwide. DoveMed

6) What about sweating problems?
Some people have reduced sweating on palms/soles; plan cooling breaks and hydration in hot weather. MedlinePlus

7) Can I pass this to my child?
Yes, often autosomal dominant—each child has a 50% chance if one parent is affected. Genetic counseling helps. PMC

8) Will my phone or office biometric scanner work?
Usually not. Ask for PIN, card, or facial/retinal ID alternatives; carry a brief physician letter for travel/immigration. PMC

9) Are there lifestyle limits?
Most activities are fine. Use padded grips, proper footwear, and dressings for long or high-friction tasks.

10) Can diet or supplements “grow” fingerprints?
No. Diet supports general skin health but cannot create ridges.

11) Are lasers or surgery needed?
Only for persistent cosmetic milia or very rare contractures; otherwise not needed.

12) Are infants safe with retinoid creams?
Retinoids are not routine in infants; many milia resolve without treatment. If used later, follow a dermatologist’s plan. Wiley Online Library

13) What tests confirm it?
A dermatology/genetics exam plus SMARCAD1 testing can confirm the diagnosis. PMC

14) Can I donate fingerprints for IDs?
You’ll likely need non-fingerprint ID methods. Keep alternative documents ready. PMC

15) Any hope for future cures?
Skin gene therapy is advancing (e.g., Vyjuvek in 2023, Zevaskyn in 2025 for EB), suggesting future platforms might one day target other genes like SMARCAD1—but nothing exists yet for Basan syndrome. U.S. Food and Drug AdministrationReuters

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: September 01, 2025.